Scalp Pathology Beyond Trichoscopy: CCCA, DLE Scalp, Cutaneous LSA, Scarring Alopecias
Trichoscopy of the scarring alopecias: peripilar grey-white halos, follicular keratin plugs, follicular red dots, tufted hairs, and pinpoint white dots map to histology and guide management.
In brief
Trichoscopy of scarring alopecias is built on a small set of reproducible features: peripilar pigmentation patterns, perifollicular scale or keratin plugs, follicular dots (red, blue-grey, or white), interfollicular vessels, and tufting. Mapping these to clinical phenotype separates lichen planopilaris and frontal fibrosing alopecia from central centrifugal cicatricial alopecia, scalp discoid lupus, pseudopelade of Brocq, dissecting cellulitis, folliculitis decalvans, and acne keloidalis nuchae. Early diagnosis is decisive because scarring is irreversible.
Must-remember points
Clinical content
01Central centrifugal cicatricial alopecia (CCCA) is the most common scarring alopecia in women of African descent. Classical trichoscopy (Miteva 2014) shows a peripilar grey-white halo (an annular hypopigmented zone of 1 mm or so around emerging hair shafts), variable shaft caliber heterogeneity, pinpoint white dots representing fibrosed follicular ostia, and a honeycomb pigmented network on the surrounding scalp. Pohl-Pinkus constrictions (segmental shaft thinning) reflect intermittent hair growth disruption. Disease starts at the vertex and centrifugally extends. Histology shows premature desquamation of the inner root sheath and concentric perifollicular fibrosis. Management combines aggressive hair-care modification, topical and intralesional steroids, oral antifibrotic agents (doxycycline, hydroxychloroquine), and increasingly minoxidil to support residual non-scarring miniaturized hairs.
02Discoid lupus erythematosus on the scalp shows a distinctive trichoscopy: large, yellow to brown follicular keratin plugs, branching arborizing telangiectasias on the surrounding scalp, follicular red dots (especially in early disease and around residual hairs), and structureless red and blue-grey areas. Late disease shows white scarring patches, loss of follicular ostia, and milky-red areas. Early DLE can show all these features without complete loss of hairs, allowing time-window diagnosis and treatment with intralesional triamcinolone, topical or oral hydroxychloroquine, and immunosuppressants. Histology demonstrates basal vacuolar interface change, perivascular and perifollicular lymphocytic infiltrate, and dermal mucin.
03Lichen planopilaris (LPP) and its frontal fibrosing alopecia (FFA) variant are covered in detail in the dedicated trichoscopy topic. Briefly, LPP shows peripilar tubular casts (white-grey perifollicular scale) and absent follicular ostia in scarred zones; FFA adds vellus hair loss, pale pink to ivory atrophic scalp, and frequent eyebrow and body hair loss. Cross-reference to the trichoscopy topic for the full inflammatory pattern.
04Cutaneous lichen sclerosus (LSA) on the scalp is rare, but when it occurs trichoscopy shows ivory-white structureless areas, comedo-like openings (yellow follicular plugs), peripheral pigment network, and absent or fibrosed follicular ostia in advanced lesions. The hair-bearing extragenital LSA pattern is similar to that of vulvar and trunk LSA, with white sclerotic background and follicular plugging. Treatment is high-potency topical steroid and consideration of topical calcineurin inhibitor.
05Pseudopelade of Brocq is the so-called footprints in the snow pattern: irregular, atrophic, ivory-white patches without follicular ostia, scattered across the scalp of a middle-aged woman, with absent inflammation and absent perifollicular changes. Trichoscopy is dominated by white interfollicular structureless areas and absent follicular openings; vessels are minimal. Whether pseudopelade is a distinct entity or the burnt-out end stage of LPP or DLE is debated. Histology in active disease may show only mild perifollicular fibrosis and minimal lymphocytic infiltrate.
06Dissecting cellulitis of the scalp (Hoffman disease) is part of the follicular occlusion tetrad with hidradenitis suppurativa, acne conglobata, and pilonidal sinus. Trichoscopy shows yellow structureless areas and yellow dots over confluent boggy nodules, follicular pustules, sinus tracts, and three-dimensional yellow-brown blotches. Hair loss is patchy in early disease and scarring in chronic disease. Treatment escalates from topical and intralesional steroids and tetracyclines to isotretinoin, biologic therapy (TNF inhibitors, increasingly IL-17 inhibitors), and surgical drainage or excision for recalcitrant sinuses.
07Folliculitis decalvans is the prototypical primary neutrophilic scarring alopecia. Trichoscopy shows yellow structureless areas, perifollicular white-yellow scale, and the pathognomonic tufted hairs (polytrichia): clusters of 5 or more shafts emerging from a single dilated follicular ostium. Surrounding scalp shows follicular pustules and erosions. Bacterial culture (Staphylococcus aureus is the typical isolate) supports prolonged combination antibiotic therapy (rifampin plus clindamycin or rifampin plus other macrolides), with isotretinoin and biologic options for refractory disease.
08Acne keloidalis nuchae presents as firm follicular papules and pustules at the occipital scalp and posterior neck of young men, often skin of color, evolving into keloid-like plaques and tufted hairs. Trichoscopy shows perifollicular white-yellow scale, dilated follicular openings, polytrichia, and structureless red areas with arborizing vessels in chronic disease. Treatment combines mechanical hair-care advice (avoiding close shaves), topical and intralesional steroids, oral tetracyclines, isotretinoin, and laser hair reduction; surgical excision is reserved for severe keloid-like disease.
09Putting trichoscopy into a clinical workflow: examine the entire scalp first to identify pattern (vertex versus frontal versus occipital, single patch versus multifocal), then examine three or more representative areas under polarized dermoscopy, and document follicular density, ostia, peripilar findings, scale color, vessels, and tufting. Combine with clinical history and selectively biopsy the active edge for cases with diagnostic uncertainty or before high-cost or long-term therapy.
Key dermoscopic features
High yield clinical points15 pearls in 4 groups
Recognition & pattern analysis
8 pointsManagement & treatment
4 pointsPitfalls & mimics
1 pointWhen to biopsy
2 pointsLectures covering this topic5 lectures
Notable updates & conceptual milestones5 updates
Peripilar grey-white halo as early CCCA biomarker
2014Miteva and Tosti (2014, J Am Acad Dermatol) characterized the peripilar grey-white halo as the most reproducible early trichoscopic feature of CCCA, allowing diagnosis before clinical thinning and informing preventive intervention.
Trichoscopic atlas of scarring alopecias
2008-2014Series and reviews (Rakowska 2014, Rudnicka 2008-2014, Inui 2014) standardized the trichoscopic vocabulary for scarring alopecias and built the diagnostic algorithm now used at most academic clinics.
Hydroxychloroquine, doxycycline, and minoxidil in CCCA
2018-2026Expert consensus and series (e.g., Miteva, Olsen) support combined oral antifibrotic therapy with hydroxychloroquine, low-dose tetracyclines, and topical or oral minoxidil to slow disease progression and improve cosmetically apparent residual hair.
Biologic therapy for refractory dissecting cellulitis and folliculitis decalvans
2018-2026Adalimumab and other TNF inhibitors, with growing interest in IL-17 and IL-23 inhibitors, have shown efficacy in case series for treatment-refractory dissecting cellulitis and folliculitis decalvans.
Standardized trichoscopy reporting and longitudinal photography
2020-2026Adoption of standardized trichoscopy zones and serial photographs improves the reliability of disease activity assessment and treatment response in clinical trials of scarring alopecias.
Bottom line
Beyond classic LPP and FFA, the scarring alopecias share a small lexicon of trichoscopic features: peripilar halos, follicular plugs, follicular red dots, tufted hairs, footprints in the snow, and yellow structureless areas. Recognizing these patterns early and choosing the active edge for biopsy preserves hair and avoids irreversible scarring.
Multimodal imaging combining trichoscopy with line-field OCT and reflectance confocal microscopy is moving toward noninvasive, in vivo histology of the scarring scalp, while emerging biologic and antifibrotic therapies expand options for refractory CCCA, FFA, dissecting cellulitis, and folliculitis decalvans.
References
Sources cited in the lecture content or that underpin the clinical points above. Verify with primary sources before practice changes.
- [1]Miteva M, Tosti A. Dermoscopy guided scalp biopsy in cicatricial alopecia. J Eur Acad Dermatol Venereol. 2013;27(10):1299-1303.PubMed: 22449222DOI: 10.1111/j.1468-3083.2012.04530.x· Established trichoscopy-guided biopsy site selection in scarring alopecias and characterized peripilar pigmentation findings.
- [2]Miteva M, Tosti A. Hair and scalp dermatoscopy. J Am Acad Dermatol. 2012;67(5):1040-1048.PubMed: 22405573DOI: 10.1016/j.jaad.2012.02.013· Comprehensive review of trichoscopic features across non-scarring and scarring alopecias.
- [3]Tosti A, Torres F, Miteva M, et al. Follicular red dots: a novel dermoscopic pattern observed in scalp discoid lupus erythematosus. Arch Dermatol. 2009;145(12):1406-1409.PubMed: 20026850DOI: 10.1001/archdermatol.2009.277· Original description of follicular red dots as an early reversible trichoscopic feature of scalp DLE.
- [4]Rakowska A, Slowinska M, Kowalska-Oledzka E, et al. Trichoscopy of cicatricial alopecia. J Drugs Dermatol. 2012;11(6):753-758.PubMed: 22648224· Trichoscopic classification of cicatricial alopecias including LPP, FFA, DLE, folliculitis decalvans, and dissecting cellulitis.
- [5]Inui S. Trichoscopy for common hair loss diseases: algorithmic method for diagnosis. J Dermatol. 2011;38(1):71-75.PubMed: 21175759DOI: 10.1111/j.1346-8138.2010.01119.x· Algorithm-based trichoscopy approach to common hair loss diseases including scarring alopecias.
- [6]Otberg N, Wu WY, McElwee KJ, Shapiro J. Folliculitis decalvans. Dermatol Ther. 2008;21(4):238-244.PubMed: 18715292DOI: 10.1111/j.1529-8019.2008.00204.x· Clinical and therapeutic review of folliculitis decalvans including the role of tufted hairs and combination antibiotics.
- [7]Ogunbiyi A. Acne keloidalis nuchae: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 2016;9:483-489.PubMed: 28008278DOI: 10.2147/CCID.S99225· Comprehensive review of acne keloidalis nuchae epidemiology, presentation, and management.